Diabetes drug may decrease COVID-19 death risk in women
Companies, agencies, institutions, etc
The Lancet Healthy Longevity
Metformin
the University of Minnesota Medical School
UnitedHealth Group
UHG
Clinical Discovery Claims Database
UHG Research and Development
MNT
People
COVID-19.Metformin
Glucophage
Deneen Vojta
Carolyn BramanteDr
Christopher Tignanelli
Ken Cohen
Groups
COVID-19
Physical locations
No matching tags
Places
No matching tags
Locations
the United States
Minneapolis
Miami
FL
U.S.
Bramante
Events
No matching tags
Summary
A recent study found an association between metformin and a significantly reduced mortality risk in women with type 2 diabetes or obesity who were hospitalized with COVID-19.Metformin is a first-line medication for treating type 2 diabetes, and many in the United States use the branded version Glucophage.
As said here by Lori Uildriks, Pharm.D., BCPS, BCGP